BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31952864)

  • 1. Socioeconomic differences in prescription drug supplemental coverage in Canada: A repeated cross-sectional study.
    Guo EX; Sweetman A; Guindon GE
    Health Policy; 2020 Mar; 124(3):252-260. PubMed ID: 31952864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inequity in insurance coverage for prescription drugs in New Brunswick, Canada.
    Ayodele B; Guo EX; Sweetman A; Guindon GE
    Can J Public Health; 2022 Aug; 113(4):504-518. PubMed ID: 35488147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insurance coverage and the treatment of mental illness: effect on medication and provider use.
    Mulvale G; Hurley J
    J Ment Health Policy Econ; 2008 Dec; 11(4):177-99. PubMed ID: 19096092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
    Kennedy J; Morgan S
    Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Private Insurance Coverage on Prescription Drug Use in Ontario, Canada.
    Kratzer J; Cheng L; Allin S; Law MR
    Healthc Policy; 2015 May; 10(4):62-74. PubMed ID: 26142359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of prescription drug insurance on cost related non-adherence to medications in Canada: A Heckman sample selection approach.
    Zhang Q; Laporte A
    PLoS One; 2023; 18(8):e0289776. PubMed ID: 37556420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey data.
    McLeod L; Bereza BG; Shim M; Grootendorst P
    Open Med; 2011; 5(1):e1-9. PubMed ID: 22046212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in prescription drug insurance coverage.
    Millar WJ
    Health Rep; 1999; 10(4):11-31(ENG); 9-30(FRE). PubMed ID: 10607410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does complementary private prescription drug insurance coverage affect seniors' use of publicly funded medications?
    Allin S; Law MR; Laporte A
    Health Policy; 2013 May; 110(2-3):147-55. PubMed ID: 23522381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of health services utilization by prescription drug coverage and immigration category in Ontario, Canada.
    Antonipillai V; Guindon GE; Sweetman A; Baumann A; Wahoush O; Schwartz L
    Health Policy; 2021 Oct; 125(10):1311-1321. PubMed ID: 34226053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated cost of universal public coverage of prescription drugs in Canada.
    Morgan SG; Law M; Daw JR; Abraham L; Martin D
    CMAJ; 2015 Apr; 187(7):491-497. PubMed ID: 25780047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and source of prescription eyewear insurance coverage in Ontario: a repeated population-based cross-sectional study using survey data.
    Nichani P; Trope GE; Buys YM; Markowitz SN; El-Defrawy S; Ngo G; Markowitz M; Jin YP
    CMAJ Open; 2021; 9(1):E224-E232. PubMed ID: 33731423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.
    Morgan SG; Li W; Yau B; Persaud N
    CMAJ; 2017 Feb; 189(8):E295-E302. PubMed ID: 28246223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries.
    Morgan SG; Lee A
    BMJ Open; 2017 Jan; 7(1):e014287. PubMed ID: 28143838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Income-related disparities in private prescription drug coverage in Canada.
    Bolatova T; Law MR
    CMAJ Open; 2019; 7(4):E618-E623. PubMed ID: 31604712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal prescription drug coverage in Canada: Long-promised yet undelivered.
    Morgan SG; Boothe K
    Healthc Manage Forum; 2016 Nov; 29(6):247-254. PubMed ID: 27744279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of self-reported prescription drug insurance coverage.
    Grootendorst P; Newman EC; Levine MA
    Health Rep; 2003 Feb; 14(2):35-46. PubMed ID: 12658863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal Pharmacare in Canada: A Prescription for Equity in Healthcare.
    Hajizadeh M; Edmonds S
    Int J Health Policy Manag; 2020 Mar; 9(3):91-95. PubMed ID: 32202091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Private dental and prescription-drug coverage in children: data from the medical expenditure panel survey.
    Chen AY
    Ambul Pediatr; 2004; 4(5):442-7. PubMed ID: 15369411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive risk modelling of high resource users under different prescription drug coverage policies in Ontario and Manitoba, Canada.
    Kornas K; Sarkar J; Fransoo R; Rosella LC
    BMC Health Serv Res; 2023 Jul; 23(1):768. PubMed ID: 37468878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.